awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38630959-3BF13FFF-FFB8-461B-93A5-163D2AB5A879
Q38630959-3BF13FFF-FFB8-461B-93A5-163D2AB5A879
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38630959-3BF13FFF-FFB8-461B-93A5-163D2AB5A879
Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.
P2860
Q38630959-3BF13FFF-FFB8-461B-93A5-163D2AB5A879
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38630959-3BF13FFF-FFB8-461B-93A5-163D2AB5A879
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a3400aff7dbba147c4ef75473ecee367ce2c3f80
P2860
Comparative effectiveness of infliximab and adalimumab for Crohn's disease.